Cited by 57Nicotinic Acetylcholine Receptors StudySmoking Behavior and CessationCarcinogens and Genotoxicity Assessment

The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells

Open access
Arredondo, Juan, Chernyavsky, Alex I., Grando, Sergei A.·2006·Journal of Cancer Research and Clinical Oncology

Abstract

Identification of the mechanisms leading to malignant transformation of respiratory cells may prove useful in the prevention and treatment of tobacco-related lung cancer. Nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N'-nitrosonornicotine (NNN) can induce tumors both locally and systemically. In addition to the genotoxic effect, they have been shown to affect lung cells due to ligating the nicotinic acetylcholine receptors (nAChRs) expressed on the plasma membrane. In this study, we sought to establish the role for nAChRs in malignant transformation caused by NNK and NNN. We used the BEP2D cells that represent a suitable model for studying the various stages of human bronchial carcinogenesis. We found that these cells express alpha1, alpha3, alpha5, alpha7, alpha9, alpha10, beta1, beta2, and beta4 nAChR subunits that can form high-affinity binding sites for NNK and NNN. Exposure of BEP2D cells to either NNK or NNN in both cases increased their proliferative potential which could be abolished in the presence of nAChR antagonists alpha-bungarotoxin, which worked most effectively against NNK, or mecamylamine, which was most efficient against NNN. The BEP2D cells stimulated with the nitrosamines showed multifold increases of the transcription of the PCNA and Bcl-2 genes by both real-time polymerase chain reaction and in-cell western assays. To gain a mechanistic insight into NNK- and NNN-initiated signaling, we investigated the expression of genes encoding the signal transduction effectors GATA-3, nuclear factor-kappaB, and STAT-1. Experimental results indicated that stimulation of nAChRs with NNK led to activation of all three signal transduction effectors under consideration, whereas NNN predominantly activated GATA-3 and STAT-1. The GATA-3 protein-binding activity induced by NNK and NNN correlated with elevated gene expression. The obtained results support the novel concept of receptor-mediated action of NNK and NNN placing cellular nAChRs in the center of the pathophysiologic loop, and suggest that an nAChR antagonist may serve as a chemopreventive agent.

Integrity signals

Registry

Crossref · 10.1007/s00432-006-0113-9

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Arredondo, J., Chernyavsky, A. I., & Grando, S. A.
Affiliations
University of California, Davis (US)
Corresponding author
Grando, Sergei A.
Venue
Journal of Cancer Research and Clinical Oncology
Published
2006-07-12
Volume
132
Issue
10
Pages
653-663
ISSN
  • 0084-5353 (ISSN-L)
  • 0171-5216
  • 1432-1335
OpenAlex
W2085637535
Cited by
57
References
78
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2018: 1 · 2016: 1 · 2015: 4 · 2014: 2 · 2013: 3 · 2012: 5
FWCI
2.86
Type
journal article
Language
en
Open access
Locations
  • Journal of Cancer Research and Clinical Oncology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Flight Attendant Medical Research Institute
  • National Institutes of Health
  • National Cancer Institute (CA117327, R03CA117327)
  • National Institute of Dental and Craniofacial Research (R01DE014173, DE14173)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
Keywords
nicotinic acetylcholine receptors, nitrosamines, NNK, NNN, BEP2D cells, bronchial carcinogenesis, malignant transformation, alpha-bungarotoxin, mecamylamine, nAChR antagonists, GATA3, NF-κB, STAT1, PCNA, Bcl-2, cell proliferation, chemoprevention, lung cancer
MeSH terms
Binding Sites, Bungarotoxins, Cells, Cultured, Humans, Lung, Nitrosamines, Receptors, Nicotinic, Nicotiana, Transcription, Genetic, Up-Regulation, NF-kappa B, Anticarcinogenic Agents, Nicotinic Antagonists, Proliferating Cell Nuclear Antigen, Proto-Oncogene Proteins c-bcl-2, Protein Subunits, Cell Proliferation, STAT1 Transcription Factor, GATA3 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review